QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NASDAQ:HALO

Halozyme Therapeutics Insider Trades

$40.12
+0.89 (+2.27 %)
(As of 12/4/2020 05:33 PM ET)
Add
Compare
Today's Range
$39.24
Now: $40.12
$40.45
50-Day Range
$28.00
MA: $34.95
$41.14
52-Week Range
$12.71
Now: $40.12
$41.55
Volume998,582 shs
Average Volume1.60 million shs
Market Capitalization$5.42 billion
P/E Ratio250.75
Dividend YieldN/A
Beta1.57

Insider Trades

Halozyme Therapeutics (NASDAQ:HALO) Insider Buying and Selling Activity

Insider Ownership Percentage: 2.60%
Insider Buying (Last 12 Months): $748,910.67
Insider Selling (Last 12 Months): $8,950,095.88

Insider Buying and Selling by Quarter


Halozyme Therapeutics (NASDAQ HALO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/2/2020Kenneth J KelleyDirectorSell31,792$41.00$1,303,472.00234,919  
11/27/2020Kenneth J KelleyDirectorSell10,000$41.25$412,500.00276,711  
11/25/2020Helen TorleyCEOSell50,000$40.73$2,036,500.00530,522  
11/25/2020Jeffrey William HendersonDirectorSell24,498$40.08$981,879.8447,609  
11/20/2020Michael J LabarreSVPSell12,000$38.76$465,120.00142,689  
10/20/2020Michael J LabarreSVPSell12,000$30.43$365,160.00146,800  
9/21/2020Michael J LabarreSVPSell12,000$26.91$322,920.00158,800  
9/11/2020Connie MatsuiDirectorSell32,000$27.06$865,920.00216,753  
8/20/2020Michael J LabarreSVPSell12,000$28.30$339,600.00170,800  
8/13/2020James M DalyDirectorSell34,337$29.12$999,893.4431,365  
7/20/2020Michael J LabarreSVPSell12,000$29.01$348,120.00182,800  
5/20/2020Michael J LabarreSVPSell21,387$23.80$509,010.60197,574  
3/19/2020Kenneth J KelleyDirectorBuy52,629$14.23$748,910.67242,467  
8/3/2019Dimitrios ChondrosSVPSell1,328$16.70$22,177.6038,584  
8/28/2018Randal J KirkMajor ShareholderSell644,998$18.08$11,661,563.843,562,388  
8/23/2018Randal J KirkMajor ShareholderSell1,194,462$17.65$21,082,254.303,562,388  
8/21/2018Randal J KirkMajor ShareholderSell161,246$17.15$2,765,368.903,562,388  
8/16/2018Randal J KirkMajor ShareholderSell490,072$17.30$8,478,245.603,562,388  
8/14/2018Randal J KirkMajor ShareholderSell303,168$17.36$5,262,996.483,562,388  
8/10/2018Randal J KirkMajor ShareholderSell572,804$17.35$9,938,149.403,562,388  
8/8/2018Randal J KirkMajor ShareholderSell146,718$17.52$2,570,499.363,562,388  
7/27/2018Randal J KirkMajor ShareholderSell302,827$17.24$5,220,737.483,562,388  
7/25/2018Randal J KirkMajor ShareholderSell103,900$17.32$1,799,548.003,562,388  
6/29/2018Randal J KirkMajor ShareholderSell304,321$17.04$5,185,629.843,562,388  
6/27/2018Randal J KirkMajor ShareholderSell53,505$17.34$927,776.703,562,388  
8/20/2015Laurie StelzerCFOBuy10,000$17.24$172,400.00  
6/18/2015Kenneth J KelleyDirectorSell20,000$21.00$420,000.00  
9/16/2014David A RamsayCFOBuy25,000$8.90$222,500.00  
9/16/2014Helen TorleyCEOBuy50,000$8.92$446,000.00  
8/19/2014John Stuart PattonDirectorSell75,000$9.96$747,000.00  
5/15/2014Robert EnglerDirectorSell126,700$7.56$957,852.00233,176  
9/16/2013John Stuart PattonDirectorSell75,000$9.13$684,750.00155,000  
8/19/2013H. Michael ShepardVPSell10,000$7.11$71,100.00  
8/14/2013Kathryn FalbergDirectorBuy100,000$6.82$682,000.00280,000  
11/29/2012Robert EnglerDirectorBuy15,000$5.57$83,550.00  
11/14/2012James P ShafferVPBuy20,000$5.22$104,400.00  
11/13/2012Kathryn E FalbergDirectorBuy50,000$5.21$260,500.00  
8/27/2012Kenneth J KelleyDirectorBuy20,000$5.70$114,000.00  
8/13/2012Gregory Ian FrostCEOBuy2,000$5.50$11,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.